Effect of Q10 supplementation on cardiovascular bio markers in patients undergoing open heart surgery.
Phase 2
- Conditions
- Chronic ischaemic heart disease.Chronic ischaemic heart disease, unspecified(I21-I22)
- Registration Number
- IRCT2013122815957N1
- Lead Sponsor
- Vice Chancellor for research of Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
80 patients' eligible for CABG surgery; Tehran Heart Hospital Rajai
Exclusion criteria: Patients with the following conditions (recent intake of antioxidants either warfarin. (a month) ; Valve replacement; and those with BMI above 30; Kidney disease (cr above 1.5)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of Troponin. Timepoint: Pre-intervention and post-intervention and 24-hour, seven days after surgery. Method of measurement: ELISA Kit.
- Secondary Outcome Measures
Name Time Method evels of CK-MB. Timepoint: Pre-intervention and post-intervention and 24-hour, seven days after surgery. Method of measurement: ELISA Kits.